Skip to main
LDOS
LDOS logo

Leidos Hld (LDOS) Stock Forecast & Price Target

Leidos Hld (LDOS) Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 42%
Buy 33%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Leidos Holdings Inc. has demonstrated significant improvement in its financial performance, particularly within the Health & Civil segment, where increased exam volumes have led to enhanced margins and scalable growth. The company's EBIT margins have notably increased from 14.5% in 2023 to 22.5% in 2024, with further impressive margins of 24.3% reported in the first half of 2025. Furthermore, the expectation that the Department of Veterans Affairs will reduce its claims backlog to 60,000 by the end of 2025 supports a positive outlook for sustained revenue growth in the near term.

Bears say

Leidos Holdings Inc. is facing a negative outlook primarily due to projected significant declines in margins for the latter half of 2025 compared to the first half. The company's revenue may be further pressured by a potential reduction in medical exam volumes, which constitutes a substantial risk to its margins. Additionally, a deteriorating budget environment could exacerbate these challenges, leading to waning investor sentiment regarding the stock's performance.

Leidos Hld (LDOS) has been analyzed by 12 analysts, with a consensus rating of Buy. 42% of analysts recommend a Strong Buy, 33% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Leidos Hld and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Leidos Hld (LDOS) Forecast

Analysts have given Leidos Hld (LDOS) a Buy based on their latest research and market trends.

According to 12 analysts, Leidos Hld (LDOS) has a Buy consensus rating as of Oct 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $189.83, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $189.83, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Leidos Hld (LDOS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.